Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

A case of familial paraganglioma syndrome type 4 caused by a mutation in the SDHB gene

Abstract

Background A 40-year-old man was referred to our clinic with recurrent paragangliomas. He had undergone resection of a paraganglioma superior to the right adrenal gland at 19 years of age, resection of two para-aortic paragangliomas at 39 years of age, and resection of a paraganglioma in the interatrial septum at 40 years. The patient's mother had died at age 39 years of metastases from a carotid body tumor.

Investigations MRI and CT scanning, 131I-labeled metaiodobenzylguanidine scanning, and genetic testing for a mutation in the succinate dehydrogenase complex, subunit B gene.

Diagnosis Familial paraganglioma syndrome type 4 caused by a mutation in the succinate dehydrogenase complex, subunit B gene.

Management The patient underwent two surgical procedures in our clinic. The first was to remove two para-aortic paragangliomas, and the second to remove a paraganglioma that involved both atria. The patient is at high risk for malignant disease and should undergo an annual monitoring program that consists of physical examination and measurement of his blood pressure and levels of urinary catecholamines and metanephrines. If these procedures suggest a recurrence of paraganglioma, 123I-labeled metaiodobenzylguanidine scanning should be performed. As he might develop nonfunctional tumors, however, he should also undergo CT scanning, MRI scanning, or both, of the neck, thorax, abdomen, and pelvis every 6–12 months. Genetic testing has been offered to family members.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: 131I-labeled meta-iodobenzylguanidine scanning showing abdominal paragangliomas (arrows) in the patient described (anterior view)
Figure 2: Histology of the para-aortic paragangliomas from the patient described
Figure 3: Different views of the MRI scan of interatrial septum paraganglioma in the patient described

References

  1. Titcombe AF and Wellington JL (1962) Carotid body tumour. CMAJ 87: 810–812

    CAS  Google Scholar 

  2. DeLellis RA et al. (2004) Pathology and genetics of tumours of endocrine organs. In World Health Organization Classification of Tumours, 138–159 (Eds Kleihues P and Sobin LE) Lyon, France: IARC Press

  3. Amar L et al. (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 34: 8812–8818

    Article  Google Scholar 

  4. Neumann HP et al. (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346: 1459–1466

    Article  CAS  Google Scholar 

  5. Gimenez-Roqueplo AP et al. (2003) Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 63: 5615–5621

    CAS  PubMed  Google Scholar 

  6. Yeo H and Roman S (2005) Pheochromocytoma and functional paraganglioma. Curr Opin Oncol 17: 13–18

    Article  Google Scholar 

  7. Eng C et al. (2003) A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 3: 193–202

    CAS  PubMed  Google Scholar 

  8. Baysal BE et al. (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848–851

    Article  CAS  Google Scholar 

  9. Astuti D et al. (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69: 49–54

    Article  CAS  Google Scholar 

  10. Muller U et al. (2005) SDHC mutations in hereditary paraganglioma/pheochromocytoma. Fam Cancer 4: 9–12

    Article  Google Scholar 

  11. Benn DE et al. (2006) Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 91: 827–836

    Article  CAS  Google Scholar 

  12. Bayley JP et al. (2005) The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet 6: 39–44

    Article  Google Scholar 

  13. Gimenez-Roqueplo AP et al. (2002) Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J Clin Endocrinol Metab 87: 4771–4774

    Article  CAS  Google Scholar 

  14. Esteban MA and Maxwell PH (2005) HIF, a missing link between metabolism and cancer. Nat Med 11: 1047–1048

    Article  CAS  Google Scholar 

  15. Neuman HP et al. (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292: 943–951

    Article  Google Scholar 

  16. Jin Y et al. (1996) Clonal chromosome abnormalities in two chemodectomas. Genes Chromosomes Cancer 15: 178–181

    CAS  Google Scholar 

  17. Baylin SB et al. (1976) Clonal origin of inherited medullary thyroid carcinoma and pheochromocytoma. Science 193: 321–323

    Article  CAS  Google Scholar 

  18. Ilias I and Pacak K (2004) Anatomical and functional imaging of metastatic pheochromocytoma. Ann NY Acad Sci 1018: 495–504

    Article  CAS  Google Scholar 

  19. Sisson JC et al. (1999) Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy. Am J Clin Oncol 22: 364–370

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robyn L Houlden.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drucker, A., Houlden, R. A case of familial paraganglioma syndrome type 4 caused by a mutation in the SDHB gene. Nat Rev Endocrinol 2, 702–706 (2006). https://doi.org/10.1038/ncpendmet0342

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0342

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing